These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34449246)

  • 1. Thioredoxin Reductase Inhibition for Cancer Therapy.
    Gencheva R; Arnér ESJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
    Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
    J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
    Engelman R; Ziv T; Arnér ESJ; Benhar M
    Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
    Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
    Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
    Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
    Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TrxR1 as a potent regulator of the Nrf2-Keap1 response system.
    Cebula M; Schmidt EE; Arnér ES
    Antioxid Redox Signal; 2015 Oct; 23(10):823-53. PubMed ID: 26058897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Xu J; Cheng Q; Arnér ES
    Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells.
    Duan D; Zhang J; Yao J; Liu Y; Fang J
    J Biol Chem; 2016 May; 291(19):10021-31. PubMed ID: 27002142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
    Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J
    Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
    Du Y; Zhang H; Lu J; Holmgren A
    J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
    Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
    Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation.
    Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ES; Spyrou G
    J Biol Chem; 2004 Dec; 279(52):54510-7. PubMed ID: 15471857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
    Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
    Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
    Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy.
    Arnér ESJ
    Adv Cancer Res; 2017; 136():139-151. PubMed ID: 29054416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
    Anestål K; Arnér ES
    J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1.
    Cheng Q; Sandalova T; Lindqvist Y; Arnér ES
    J Biol Chem; 2009 Feb; 284(6):3998-4008. PubMed ID: 19054767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
    Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
    Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
    Anestål K; Prast-Nielsen S; Cenas N; Arnér ES
    PLoS One; 2008 Apr; 3(4):e1846. PubMed ID: 18382651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.